Guardian Wealth Advisors (North Carolina)’s Boston Scientific BSX Stock Holding History

Guardian Wealth Advisors (North Carolina)’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$239K	Buy	3,813 +118	+3%	+$9.44K	0.02%	317
2025 Q4	$352K	Sell	3,695 -25	-0.7%	-$2.45K	0.02%	272
2025 Q3	$363K	Buy	3,720 +155	+4%	+$16.1K	0.02%	260
2025 Q2	$383K	Buy	3,565 +1,036	+41%	+$105K	0.03%	229
2025 Q1	$255K	Sell	2,529 -69	-3%	-$6.95K	0.02%	273
2024 Q4	$232K	Buy	2,598 +205	+9%	+$18K	0.02%	292
2024 Q3	$201K	Buy	+2,393	New	+$189K	0.02%	269

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Guardian Wealth Advisors (North Carolina)'s BSX Position: Q1 2026 in Review

Guardian Wealth Advisors (North Carolina) increased its Boston Scientific (BSX) stake by 3.2% in Q1 2026, buying an estimated $9.44K and bringing the position to 3,813 shares worth $239K. The position accounts for 0.02% of the portfolio, ranked #317.

Guardian Wealth Advisors (North Carolina) first reported a position in BSX in Q3 2024 and has held it in 7 quarters since. The position peaked at $383K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Guardian Wealth Advisors (North Carolina) held 3,813 shares of Boston Scientific worth $239K as of Q1 2026.
Guardian Wealth Advisors (North Carolina) bought 118 Boston Scientific shares in Q1 2026, an estimated $9.44K.
Boston Scientific made up 0.02% of Guardian Wealth Advisors (North Carolina)'s portfolio in Q1 2026, its #317 holding.
Guardian Wealth Advisors (North Carolina) first reported a position in Boston Scientific in Q3 2024 and has held it in 7 quarters since.
Guardian Wealth Advisors (North Carolina)'s Boston Scientific position peaked at $383K in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Guardian Wealth Advisors (North Carolina)'s 13F filing for Q1 2026, filed 15 May 2026.